Aftertrade Broking Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Advertisement for the attention of the Equity Shareholders of the Aspira Pathlab & Diagnostics ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Five members of the Bhanushali family along with a related party (Mrs. Shraddha Nikunj Mange) successfully completed an open offer to acquire shares in Aspira Pathlab & Diagnostics Limited. The offer, which opened on April 15, 2026 and closed on April 28, 2026, was for 26,76,180 shares (26% of equity) at Rs. 55 per share. However, only 22,82,507 shares were tendered and accepted, representing 22.18% of equity, with total consideration of Rs. 12.55 crore paid. Following the offer, the acquirer group now holds 46% of the company (up from 23.82% pre-offer), while public shareholding reduced from 75.75% to 53.57%.
The acquirer group has gained significant control with 46% stake, reducing the company's public float to 53.57%. This substantial change in ownership structure may lead to increased volatility or price movement as the market adjusts to the new controlling shareholders.